A significant amount of experimental evidence supports the notion that changes in LOX levels alter ECM mechanics and contribute to cancer progression, and several studies have demonstrated that LOX activity is closely correlated with tumor stiffness and the invasiveness of cancer [6,20,44]. This evidence concerns the gene LOX and cancer.